1
Participants
Start Date
October 29, 2020
Primary Completion Date
December 11, 2020
Study Completion Date
December 11, 2020
Vedolizumab
standard vedolizumab induction (300mg IV at week 0, 2, 6)
Stanford University, Stanford
University of Western Ontario, London
Collaborators (1)
Takeda
INDUSTRY
University of Western Ontario, Canada
OTHER
University of California, San Diego
OTHER
Stanford University
OTHER